Amedeo Smart

Free Medical Literature Service


 

Amedeo

Alzheimer's Disease

  Free Subscription

29.08.2022

2 Alzheimer Dis Assoc Disord
8 Alzheimers Dement
4 Ann Neurol
1 BMC Geriatr
2 Curr Alzheimer Res
12 J Alzheimers Dis
1 J Neurochem
1 J Neurol
1 J Neurol Neurosurg Psychiatry
1 Nat Rev Neurol
1 Neurobiol Aging
1 Neurochem Res
4 Neurology
1 Neurosci Lett
2 PLoS One
3 Science



    Alzheimer Dis Assoc Disord

  1. JOSHI H, Shah J, Abu-Hijleh FA, Patel V, et al
    Decreased Expression of Cerebral Dopamine Neurotrophic Factor in Platelets of Probable Alzheimer Patients.
    Alzheimer Dis Assoc Disord. 2022;36:269-271.
    >> Share

  2. KIM HJ, Jo S, Lee S, Oh M, et al
    Crossed Hemispheric Accumulation of beta-Amyloid and Tau Protein in a Patient With Typical Alzheimer Disease.
    Alzheimer Dis Assoc Disord. 2022;36:263-265.
    >> Share


    Alzheimers Dement

  3. JIANG L, Li JC, Tang BS, Guo JF, et al
    Lack of bidirectional association between age-related macular degeneration and Alzheimer's disease: A Mendelian randomization study.
    Alzheimers Dement. 2022 Aug 25. doi: 10.1002/alz.12775.
    >> Share

  4. LUTZ MW, Khachaturian AS, Zetterberg H, Blennow K, et al
    Biomarkers of Alzheimer syndrome and related dementias: A&D author's guide.
    Alzheimers Dement. 2022 Aug 25. doi: 10.1002/alz.12772.
    >> Share

  5. FRIKKE-SCHMIDT R, Hegazy SH, Rasmussen IJ, Nordestgaard BG, et al
    Observational and genetic studies of C-reactive protein levels and risk of Alzheimer's disease.
    Alzheimers Dement. 2022 Aug 21. doi: 10.1002/alz.12742.
    >> Share

  6. PETERSEN RC, Graf A, Carrillo MC, Weber CJ, et al
    Current understanding of AD pathophysiology and impact of amyloid beta-targeted treatments on biomarkers and clinical endpoints.
    Alzheimers Dement. 2022;18:1586.
    >> Share

  7. HACHINSKI V
    The comprehensive, customized, cost-effective approach (CCCAP) to prevention of dementia.
    Alzheimers Dement. 2022;18:1565-1568.
    >> Share

  8. LENNON JC, Aita SL, Bene VAD, Rhoads T, et al
    Black and White individuals differ in dementia prevalence, risk factors, and symptomatic presentation.
    Alzheimers Dement. 2022;18:1461-1471.
    >> Share

  9. PERLUIGI M, Picca A, Montanari E, Calvani R, et al
    Aberrant crosstalk between insulin signaling and mTOR in young Down syndrome individuals revealed by neuronal-derived extracellular vesicles.
    Alzheimers Dement. 2022;18:1498-1510.
    >> Share

  10. PAJEWSKI NM, Elahi FM, Tamura MK, Hinman JD, et al
    Plasma amyloid beta, neurofilament light chain, and total tau in the Systolic Blood Pressure Intervention Trial (SPRINT).
    Alzheimers Dement. 2022;18:1472-1483.
    >> Share


    Ann Neurol

  11. BACHMANN D, Roman ZJ, Buchmann A, Zuber I, et al
    Lifestyle Affects Amyloid Burden and Cognition Differently in Men and Women.
    Ann Neurol. 2022;92:451-463.
    >> Share

  12. SMIRNOV DS, Salmon DP, Galasko D, Edland SD, et al
    TDP-43 Pathology Exacerbates Cognitive Decline in Primary Age-Related Tauopathy.
    Ann Neurol. 2022;92:425-438.
    >> Share

  13. HU H, Bi YL, Shen XN, Ma YH, et al
    Application of the Amyloid/Tau/Neurodegeneration Framework in Cognitively Intact Adults: The CABLE Study.
    Ann Neurol. 2022;92:439-450.
    >> Share

  14. AL-MUBARAK B, Ahmed Nour M, Schumacher-Schuh A, Bandres-Ciga S, et al
    Globalizing research towards diverse representation in Alzheimer's and Parkinson's disease.
    Ann Neurol. 2022 Aug 24. doi: 10.1002/ana.26483.
    >> Share


    BMC Geriatr

  15. ALJEZAWI M, Al Qadire M, Suliman M, Al Omari O, et al
    Undergraduate nursing students' knowledge of and attitudes toward people with alzheimer's disease.
    BMC Geriatr. 2022;22:691.
    >> Share


    Curr Alzheimer Res

  16. KOBAYASHI R, Hayashi H, Kawakatsu S, Shibuya Y, et al
    Comparing Medial Temporal Atrophy Between Early-Onset Semantic Dementia and Early-Onset Alzheimer's Disease Using Voxel-Based Morphometry: A Multicenter MRI Study.
    Curr Alzheimer Res. 2022 Aug 20. pii: CAR-EPUB-125701.
    >> Share

  17. DI MECO A, Kemal S, Popovic J, Chandra S, et al
    Poloxamer-188 Exacerbates Brain Amyloidosis, Presynaptic Dystrophies, and Pathogenic Microglial Activation in 5XFAD Mice.
    Curr Alzheimer Res. 2022;19:317-329.
    >> Share


    J Alzheimers Dis

  18. VYHNALEK M, Jester DJ, Andel R, Horakova H, et al
    Contribution of Memory Tests to Early Identification of Conversion from Amnestic Mild Cognitive Impairment to Dementia.
    J Alzheimers Dis. 2022;88:1397-1409.
    >> Share

  19. GOLDBERG SM, Zhao Y, Cheng Y, Weinstein AM, et al
    Clinical Progression of Baseline Risk States for Mild Cognitive Impairment.
    J Alzheimers Dis. 2022;88:1377-1384.
    >> Share

  20. RUBIN-NOROWITZ M, Lipton RB, Petersen K, Ezzati A, et al
    Association of Depressive Symptoms and Cognition in Older Adults Without Dementia Across Different Biomarker Profiles.
    J Alzheimers Dis. 2022;88:1385-1395.
    >> Share

  21. HE XY, Dobkin C, Brown WT, Yang SY, et al
    3-Hydroxyacyl-CoA and Alcohol Dehydrogenase Activities of Mitochondrial Type 10 17beta-Hydroxysteroid Dehydrogenase in Neurodegeneration Study.
    J Alzheimers Dis. 2022;88:1487-1497.
    >> Share

  22. POLCHER A, Wolfsgruber S, Peters O, Frolich L, et al
    A Comparison of Operational Definitions for Mild Cognitive Impairment.
    J Alzheimers Dis. 2022;88:1663-1678.
    >> Share

  23. TSUJIMOTO M, Suzuki K, Saji N, Sakurai T, et al
    Organized Registration for the Assessment of Dementia by the Nationwide General Consortium Toward Effective Treatment (ORANGE) Registry: Current Status and Perspectives of Mild Cognitive Impairment.
    J Alzheimers Dis. 2022;88:1423-1433.
    >> Share

  24. ZHANG X, Cong R, Geng T, Zhang J, et al
    Assessment of the Causal Effect of IgG N-Glycosylation Level on Risk of Dementia: A 2-Sample Mendelian Randomization Study.
    J Alzheimers Dis. 2022;88:1435-1441.
    >> Share

  25. ZHU MH, Jogdand AH, Jang J, Nagella SC, et al
    Evoked Cortical Depolarizations Before and After the Amyloid Plaque Accumulation: Voltage Imaging Study.
    J Alzheimers Dis. 2022;88:1443-1458.
    >> Share

  26. BOUJELBANE MA, Trabelsi K, Boukhris O, Kacem FH, et al
    The Use of Digital Technology to Assess Cognitive Function in Tunisian Adults.
    J Alzheimers Dis. 2022;88:1545-1552.
    >> Share

  27. YOSHIDA K, Seo M, Luo Y, Sahker E, et al
    Personalized Prediction of Alzheimer's Disease and Its Treatment Effects by Donepezil: An Individual Participant Data Meta-Analysis of Eight Randomized Controlled Trials.
    J Alzheimers Dis. 2022 Aug 16. pii: JAD220263. doi: 10.3233/JAD-220263.
    >> Share

  28. YANG J, Oveisgharan S, Liu X, Wilson RS, et al
    Risk Models Based on Non-Cognitive Measures May Identify Presymptomatic Alzheimer's Disease.
    J Alzheimers Dis. 2022 Aug 17. pii: JAD220446. doi: 10.3233/JAD-220446.
    >> Share

  29. DOREY CK, Gierhart D, Fitch KA, Crandell I, et al
    Low Xanthophylls, Retinol, Lycopene, and Tocopherols in Gray and White Matter of Brains with Alzheimer's Disease.
    J Alzheimers Dis. 2022 Aug 16. pii: JAD220460. doi: 10.3233/JAD-220460.
    >> Share


    J Neurochem

  30. PEDRINI S, Doecke JD, Hone E, Wang P, et al
    Plasma high-density lipoprotein cargo is altered in Alzheimer's disease and is associated with regional brain volume.
    J Neurochem. 2022 Jul 30. doi: 10.1111/jnc.15681.
    >> Share


    J Neurol

  31. SINGH NA, Graff-Radford J, Machulda MM, Schwarz CG, et al
    Atypical Alzheimer's disease phenotypes with normal or borderline PET biomarker profiles.
    J Neurol. 2022 Aug 24. pii: 10.1007/s00415-022-11330.
    >> Share


    J Neurol Neurosurg Psychiatry

  32. HALBGEBAUER S, Steinacker P, Hengge S, Oeckl P, et al
    CSF levels of SNAP-25 are increased early in Creutzfeldt-Jakob and Alzheimer's disease.
    J Neurol Neurosurg Psychiatry. 2022 Aug 22. pii: jnnp-2021-328646.
    >> Share


    Nat Rev Neurol

  33. WOOD H
    Reactive astrocyte biomarkers mirror Alzheimer disease pathology.
    Nat Rev Neurol. 2022 Aug 23. pii: 10.1038/s41582-022-00713.
    >> Share


    Neurobiol Aging

  34. THORP JG, Mitchell BL, Gerring ZF, Ong JS, et al
    Genetic evidence that the causal association of educational attainment with reduced risk of Alzheimer's disease is driven by intelligence.
    Neurobiol Aging. 2022 Jul 30. pii: S0197-4580(22)00164.
    >> Share


    Neurochem Res

  35. BHATIA S, Singh M, Singh T, Singh V, et al
    Scrutinizing the Therapeutic Potential of PROTACs in the Management of Alzheimer's Disease.
    Neurochem Res. 2022 Aug 20. pii: 10.1007/s11064-022-03722.
    >> Share


    Neurology

  36. JEONG SH, Cha J, Park M, Jung JH, et al
    Association of Enlarged Perivascular Spaces With Amyloid Burden and Cognitive Decline in Alzheimer Disease Continuum.
    Neurology. 2022 Aug 19. pii: WNL.0000000000200989.
    >> Share

  37. BILLETTE OV, Ziegler G, Aruci M, Schutze H, et al
    Novelty-Related fMRI Responses of Precuneus and Medial Temporal Regions in Individuals at Risk for Alzheimer Disease.
    Neurology. 2022;99:e775-e788.
    >> Share

  38. ROSTAMZADEH A, Bohr L, Wagner M, Baethge C, et al
    Progression of Subjective Cognitive Decline to MCI or Dementia in Relation to Biomarkers for Alzheimer Disease: A Meta-Analysis.
    Neurology. 2022 Aug 26. pii: WNL.0000000000201072.
    >> Share

  39. SALMON DP, Smirnov DS, Coughlin DG, Hamilton JM, et al
    Perception of Fragmented Letters by Patients With Pathologically Confirmed Dementia With Lewy Bodies or Alzheimer Disease.
    Neurology. 2022 Aug 26. pii: WNL.0000000000201068.
    >> Share


    Neurosci Lett

  40. TONDELLI M, Salemme S, Vinceti G, Bedin R, et al
    Predictive value of phospho-tau/total-tau ratio in amyloid-negative Mild Cognitive Impairment.
    Neurosci Lett. 2022;787:136811.
    >> Share


    PLoS One

  41. FAVERO F, Barberis E, Gagliardi M, Espinoza S, et al
    A Metabologenomic approach reveals alterations in the gut microbiota of a mouse model of Alzheimer's disease.
    PLoS One. 2022;17:e0273036.
    >> Share

  42. ACQUARELLI J, van Laarhoven T, Postma GJ, Jansen JJ, et al
    Convolutional neural networks to predict brain tumor grades and Alzheimer's disease with MR spectroscopic imaging data.
    PLoS One. 2022;17:e0268881.
    >> Share


    Science

  43. ASHE KH
    Alzheimer's target still viable but untested.
    Science. 2022;377:935.
    >> Share

  44. SELKOE D, Cummings J
    News story miscasts Alzheimer's science.
    Science. 2022;377:934-935.
    >> Share

  45. COOPER YA, Teyssier N, Drager NM, Guo Q, et al
    Functional regulatory variants implicate distinct transcriptional networks in dementia.
    Science. 2022;377:eabi8654.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016